KETOCONAZOLE FOAM

KETOCONAZOLE FOAM was reported 15122 times

These side effects are most commonly reported by patients taking KETOCONAZOLE FOAM:

# Side effect Count
0 DRUG INEFFECTIVE 1468
1 OFF LABEL USE 1136
2 FATIGUE 863
3 PRURITUS 863
4 RASH 762
5 NAUSEA 752
6 DIARRHOEA 719
7 HEADACHE 661
8 PAIN 632
9 PSORIASIS 612
10 DYSPNOEA 566
11 DIZZINESS 553
12 PRODUCT USE IN UNAPPROVED INDICATION 542
13 ARTHRALGIA 531
14 CHRONIC KIDNEY DISEASE 488
15 ANXIETY 417
16 CONDITION AGGRAVATED 416
17 FALL 399
18 ASTHENIA 398
19 PRODUCT DOSE OMISSION ISSUE 393
20 RENAL FAILURE 392
21 VOMITING 388
22 DRUG INTERACTION 379
23 DEATH 376
24 ACUTE KIDNEY INJURY 355
25 PNEUMONIA 354
26 ERYTHEMA 353
27 DRY SKIN 338
28 ALOPECIA 337
29 WEIGHT DECREASED 332
30 MALAISE 324
31 SKIN EXFOLIATION 320
32 COUGH 313
33 DEPRESSION 305
34 PAIN IN EXTREMITY 294
35 URINARY TRACT INFECTION 275
36 BACK PAIN 263
37 CONSTIPATION 263
38 INSOMNIA 260
39 PERIPHERAL SWELLING 255
40 PYREXIA 255
41 INJECTION SITE PAIN 230
42 PRODUCT USE ISSUE 224
43 DECREASED APPETITE 213
44 GAIT DISTURBANCE 209
45 MUSCLE SPASMS 206
46 TREMOR 202
47 ANAEMIA 200
48 HYPERTENSION 200
49 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 200
50 WEIGHT INCREASED 198
51 DERMATITIS ATOPIC 194
52 SOMNOLENCE 194
53 COVID-19 193
54 EMOTIONAL DISTRESS 190
55 HYPERSENSITIVITY 188
56 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 186
57 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 185
58 CHEST PAIN 184
59 FEELING ABNORMAL 184
60 ABDOMINAL PAIN 182
61 NASOPHARYNGITIS 174
62 HYPOTENSION 171
63 MYALGIA 169
64 INFECTION 168
65 MUSCULAR WEAKNESS 168
66 ABDOMINAL PAIN UPPER 163
67 DEHYDRATION 159
68 HYPOAESTHESIA 158
69 ECZEMA 156
70 PARAESTHESIA 155
71 URTICARIA 152
72 ABDOMINAL DISCOMFORT 151
73 ANHEDONIA 151
74 SINUSITIS 151
75 DRUG HYPERSENSITIVITY 150
76 OEDEMA PERIPHERAL 150
77 BLOOD PRESSURE INCREASED 148
78 CONFUSIONAL STATE 147
79 ADVERSE DRUG REACTION 142
80 ASTHMA 141
81 NEUROPATHY PERIPHERAL 141
82 GASTROOESOPHAGEAL REFLUX DISEASE 138
83 LOSS OF CONSCIOUSNESS 138
84 SKIN IRRITATION 138
85 END STAGE RENAL DISEASE 136
86 VISION BLURRED 135
87 TREATMENT FAILURE 133
88 PSORIATIC ARTHROPATHY 131
89 ARTHRITIS 125
90 MEMORY IMPAIRMENT 125
91 MIGRAINE 125
92 THROMBOCYTOPENIA 124
93 BLOOD GLUCOSE INCREASED 123
94 ILLNESS 122
95 INCORRECT DOSE ADMINISTERED 122
96 JOINT SWELLING 122
97 VISUAL IMPAIRMENT 118
98 BURNING SENSATION 117
99 DISEASE PROGRESSION 117
100 HYPOKALAEMIA 115
101 OROPHARYNGEAL PAIN 115
102 SEPSIS 115
103 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 115
104 FUNGAL INFECTION 113
105 HOSPITALISATION 113
106 DYSPEPSIA 111
107 BALANCE DISORDER 110
108 CELLULITIS 109
109 HEART RATE INCREASED 108
110 HYPERHIDROSIS 108
111 SYNCOPE 108
112 PALPITATIONS 107
113 INFLUENZA 106
114 BRONCHITIS 105
115 HAIR TEXTURE ABNORMAL 105
116 SURGERY 105
117 CARDIAC FAILURE CONGESTIVE 104
118 SEIZURE 104
119 SWELLING 104
120 DYSPHAGIA 103
121 HALLUCINATION 103
122 DRY MOUTH 101
123 HOT FLUSH 101
124 THERAPEUTIC RESPONSE UNEXPECTED 101
125 ABDOMINAL DISTENSION 98
126 ECONOMIC PROBLEM 98
127 SKIN BURNING SENSATION 98
128 NEUTROPENIA 97
129 ACNE 96
130 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 96
131 CONTUSION 96
132 GASTROINTESTINAL DISORDER 96
133 RASH PRURITIC 96
134 CEREBROVASCULAR ACCIDENT 95
135 SLEEP DISORDER 94
136 DERMATITIS 93
137 EYE PAIN 93
138 SKIN DISORDER 93
139 ATRIAL FIBRILLATION 92
140 BLOOD CREATININE INCREASED 92
141 DRY EYE 92
142 SWELLING FACE 92
143 HAEMOGLOBIN DECREASED 91
144 RHABDOMYOLYSIS 91
145 RASH ERYTHEMATOUS 90
146 BLISTER 86
147 NEPHROGENIC ANAEMIA 86
148 RENAL IMPAIRMENT 86
149 RHINORRHOEA 86
150 PRODUCT DOSE OMISSION 85
151 TACHYCARDIA 85
152 CHILLS 84
153 DRUG INTOLERANCE 84
154 SKIN LESION 84
155 ALANINE AMINOTRANSFERASE INCREASED 83
156 HEPATIC ENZYME INCREASED 83
157 OSTEOARTHRITIS 83
158 SUICIDAL IDEATION 83
159 CHEST DISCOMFORT 82
160 PULMONARY EMBOLISM 82
161 SEBORRHOEIC DERMATITIS 82
162 INJECTION SITE ERYTHEMA 81
163 MUSCULOSKELETAL STIFFNESS 81
164 THERAPY NON-RESPONDER 81
165 UNEVALUABLE EVENT 81
166 ACCIDENTAL EXPOSURE TO PRODUCT 80
167 ASPARTATE AMINOTRANSFERASE INCREASED 80
168 EYE IRRITATION 80
169 ADRENAL INSUFFICIENCY 79
170 OEDEMA 79
171 OSTEOPOROSIS 79
172 PROSTATIC SPECIFIC ANTIGEN INCREASED 79
173 SKIN DISCOLOURATION 79
174 DYSPHONIA 78
175 DRUG DOSE OMISSION 77
176 NASAL CONGESTION 77
177 MYOCARDIAL INFARCTION 76
178 THERAPEUTIC RESPONSE DECREASED 76
179 THERAPY INTERRUPTED 76
180 EPISTAXIS 75
181 STRESS 75
182 THERAPEUTIC RESPONSE SHORTENED 75
183 MOBILITY DECREASED 74
184 OCULAR HYPERAEMIA 74
185 DIABETES MELLITUS 72
186 NEPHROLITHIASIS 72
187 SLEEP APNOEA SYNDROME 72
188 WHITE BLOOD CELL COUNT DECREASED 72
189 CARDIAC DISORDER 71
190 PRODUCT QUALITY ISSUE 71
191 INTENTIONAL PRODUCT USE ISSUE 70
192 MALIGNANT NEOPLASM PROGRESSION 70
193 PLATELET COUNT DECREASED 70
194 CATARACT 69
195 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 69
196 UPPER RESPIRATORY TRACT INFECTION 69
197 BONE DENSITY DECREASED 68
198 PRODUCTIVE COUGH 68
199 RENAL INJURY 68
200 VERTIGO 68
201 INJURY 67
202 OXYGEN SATURATION DECREASED 66
203 ADVERSE EVENT 65
204 CONTRAINDICATED PRODUCT ADMINISTERED 65
205 GENERAL PHYSICAL HEALTH DETERIORATION 65
206 HAIR COLOUR CHANGES 65
207 HEPATOTOXICITY 65
208 HERPES ZOSTER 65
209 RENAL FAILURE ACUTE 65
210 GASTROINTESTINAL HAEMORRHAGE 64
211 NO ADVERSE EVENT 64
212 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64
213 BLOOD PRESSURE DECREASED 63
214 RASH MACULAR 63
215 BONE PAIN 62
216 PAPULE 62
217 THROMBOSIS 62
218 HAEMORRHAGE 61
219 INJECTION SITE BRUISING 61
220 INJECTION SITE SWELLING 61
221 SINUS DISORDER 61
222 STOMATITIS 61
223 AGITATION 60
224 EYE PRURITUS 60
225 AMNESIA 59
226 DEEP VEIN THROMBOSIS 59
227 NECK PAIN 59
228 WHEEZING 59
229 DISCOMFORT 58
230 INFLAMMATION 58
231 PLEURAL EFFUSION 58
232 RHEUMATOID ARTHRITIS 58
233 URINARY INCONTINENCE 58
234 APPLICATION SITE PAIN 57
235 BLOOD CHOLESTEROL INCREASED 57
236 ERECTILE DYSFUNCTION 57
237 FLUSHING 57
238 HYPERKALAEMIA 57
239 OSTEOPENIA 57
240 POLLAKIURIA 57
241 PRODUCT ADMINISTRATION INTERRUPTED 57
242 SKIN FISSURES 57
243 SKIN ULCER 57
244 DYSPNOEA EXERTIONAL 56
245 FEBRILE NEUTROPENIA 56
246 INTENTIONAL PRODUCT MISUSE 56
247 RESPIRATORY FAILURE 56
248 TINNITUS 56
249 SKIN PLAQUE 55
250 INJECTION SITE PRURITUS 54
251 LEUKOPENIA 54
252 DYSGEUSIA 53
253 FLUID RETENTION 53
254 LUNG DISORDER 53
255 PAIN OF SKIN 53
256 ARTHROPATHY 52
257 COGNITIVE DISORDER 52
258 DANDRUFF 52
259 FLATULENCE 52
260 HYPOGLYCAEMIA 52
261 OVERDOSE 52
262 SCAB 52
263 MATERNAL EXPOSURE DURING PREGNANCY 51
264 BRADYCARDIA 50
265 LETHARGY 50
266 SEPTIC SHOCK 50
267 THERAPEUTIC PRODUCT EFFECT DECREASED 50
268 CARDIAC ARREST 49
269 CYSTITIS 49
270 HYPERPARATHYROIDISM SECONDARY 49
271 DRUG-INDUCED LIVER INJURY 48
272 INFLUENZA LIKE ILLNESS 48
273 SKIN HAEMORRHAGE 48
274 STAPHYLOCOCCAL INFECTION 48
275 TREATMENT NONCOMPLIANCE 48
276 APPLICATION SITE PRURITUS 47
277 BLOOD ALKALINE PHOSPHATASE INCREASED 47
278 BONE DISORDER 47
279 DYSURIA 47
280 EAR INFECTION 47
281 HYPOTHYROIDISM 47
282 OSTEONECROSIS 47
283 THROAT IRRITATION 47
284 BLOOD POTASSIUM DECREASED 46
285 CHOLELITHIASIS 46
286 DEPRESSED MOOD 46
287 FEELING HOT 46
288 HYPERLIPIDAEMIA 46
289 LOCALISED INFECTION 46
290 MUSCULOSKELETAL PAIN 46
291 ELECTROCARDIOGRAM QT PROLONGED 45
292 INFUSION RELATED REACTION 45
293 LIVER FUNCTION TEST ABNORMAL 45
294 SEASONAL ALLERGY 45
295 INTENTIONAL DOSE OMISSION 44
296 NIGHT SWEATS 44
297 SPEECH DISORDER 44
298 LIVER DISORDER 43
299 OSTEONECROSIS OF JAW 43
300 DERMATITIS CONTACT 42
301 EYE DISORDER 42
302 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 42
303 INTESTINAL OBSTRUCTION 42
304 MENTAL STATUS CHANGES 42
305 HYPOXIA 41
306 LIMB INJURY 41
307 SKIN INFECTION 41
308 TOXICITY TO VARIOUS AGENTS 41
309 TUBULOINTERSTITIAL NEPHRITIS 41
310 APPLICATION SITE ERYTHEMA 40
311 BLOOD GLUCOSE DECREASED 40
312 DEAFNESS 40
313 DEVICE ISSUE 40
314 DYSKINESIA 40
315 LACRIMATION INCREASED 40
316 OSTEOMYELITIS 40
317 PAIN IN JAW 40
318 RIB FRACTURE 40
319 HAEMATURIA 39
320 LIMB DISCOMFORT 39
321 MENTAL DISORDER 39
322 PANIC ATTACK 39
323 THERAPY PARTIAL RESPONDER 39
324 BACTERIAL INFECTION 38
325 CORONARY ARTERY DISEASE 38
326 HYPERSOMNIA 38
327 INTERVERTEBRAL DISC PROTRUSION 38
328 METASTASES TO BONE 38
329 ORTHOSTATIC HYPOTENSION 38
330 SPINAL OSTEOARTHRITIS 38
331 SWOLLEN TONGUE 38
332 URINARY RETENTION 38
333 ACUTE MYOCARDIAL INFARCTION 37
334 BLOOD SODIUM DECREASED 37
335 CHROMATURIA 37
336 DISTURBANCE IN ATTENTION 37
337 EYE SWELLING 37
338 IMPAIRED GASTRIC EMPTYING 37
339 LYMPHADENOPATHY 37
340 MOUTH ULCERATION 37
341 PRODUCT DOSE OMISSION IN ERROR 37
342 RENAL DISORDER 37
343 THERAPY CESSATION 37
344 TRANSIENT ISCHAEMIC ATTACK 37
345 ABNORMAL BEHAVIOUR 36
346 ANAPHYLACTIC REACTION 36
347 DYSARTHRIA 36
348 FOOT FRACTURE 36
349 HEPATITIS 36
350 IMPAIRED HEALING 36
351 NERVOUSNESS 36
352 PANCYTOPENIA 36
353 PRE-EXISTING CONDITION IMPROVED 36
354 PROSTATE CANCER 36
355 UNDERDOSE 36
356 CARDIAC FAILURE 35
357 CONJUNCTIVITIS 35
358 FUNGAL SKIN INFECTION 35
359 HAEMORRHOIDS 35
360 HEART RATE DECREASED 35
361 HYPONATRAEMIA 35
362 IRRITABILITY 35
363 MULTIPLE SCLEROSIS RELAPSE 35
364 PARKINSON^S DISEASE 35
365 RENAL TUBULAR NECROSIS 35
366 SYSTEMIC LUPUS ERYTHEMATOSUS 35
367 GAIT INABILITY 34
368 INJECTION SITE REACTION 34
369 LIP SWELLING 34
370 SPUTUM DISCOLOURED 34
371 WHITE BLOOD CELL COUNT INCREASED 34
372 WOUND 34
373 BASAL CELL CARCINOMA 33
374 BRAIN FOG 33
375 HYPOPHAGIA 33
376 INTERNATIONAL NORMALISED RATIO INCREASED 33
377 NEURALGIA 33
378 ORAL HERPES 33
379 PANCREATITIS 33
380 POOR QUALITY SLEEP 33
381 SCAR 33
382 TOOTH DISORDER 33
383 TYPE 2 DIABETES MELLITUS 33
384 BLOOD BILIRUBIN INCREASED 32
385 CROHN^S DISEASE 32
386 EOSINOPHILIA 32
387 HAEMATOCHEZIA 32
388 HEAD INJURY 32
389 HEPATIC FAILURE 32
390 HYPERGLYCAEMIA 32
391 ORAL PAIN 32
392 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 32
393 RED BLOOD CELL COUNT DECREASED 32
394 VITAMIN D DEFICIENCY 32
395 DRUG EFFECT DECREASED 31
396 GASTRITIS 31
397 IRRITABLE BOWEL SYNDROME 31
398 MUSCULOSKELETAL DISCOMFORT 31
399 NEOPLASM MALIGNANT 31
400 NODULE 31
401 SEBORRHOEIC KERATOSIS 31
402 TOOTH INFECTION 31
403 TRANSAMINASES INCREASED 31
404 ANGIOEDEMA 30
405 CORTISOL INCREASED 30
406 DRUG RESISTANCE 30
407 EXPOSURE DURING PREGNANCY 30
408 FIBROMYALGIA 30
409 GLAUCOMA 30
410 NOCTURIA 30
411 REBOUND ACID HYPERSECRETION 30
412 TENDERNESS 30
413 CARDIO-RESPIRATORY ARREST 29
414 HIDRADENITIS 29
415 HYPOACUSIS 29
416 INTERVERTEBRAL DISC DEGENERATION 29
417 LIVER FUNCTION TEST INCREASED 29
418 MOVEMENT DISORDER 29
419 NEUTROPHIL COUNT DECREASED 29
420 PHOTOPHOBIA 29
421 RASH PAPULAR 29
422 SCRATCH 29
423 SKIN LACERATION 29
424 TOOTHACHE 29
425 ACTINIC KERATOSIS 28
426 ANKLE FRACTURE 28
427 DIPLOPIA 28
428 DIVERTICULITIS 28
429 EAR PAIN 28
430 ELECTROLYTE IMBALANCE 28
431 EXPOSURE VIA SKIN CONTACT 28
432 FULL BLOOD COUNT ABNORMAL 28
433 HAEMATOCRIT DECREASED 28
434 JAW FRACTURE 28
435 PHOTOSENSITIVITY REACTION 28
436 PNEUMONIA ASPIRATION 28
437 RESPIRATORY TRACT INFECTION 28
438 RESTLESSNESS 28
439 SKIN HYPERPIGMENTATION 28
440 TOOTH LOSS 28
441 VIRAL INFECTION 28
442 ARRHYTHMIA 27
443 BLOOD POTASSIUM INCREASED 27
444 CONVULSION 27
445 DENTAL CARIES 27
446 DISORIENTATION 27
447 DIVERTICULUM 27
448 DRUG EFFECT LESS THAN EXPECTED 27
449 FEELING COLD 27
450 HAEMOPTYSIS 27
451 HEPATIC CIRRHOSIS 27
452 INTERTRIGO 27
453 JAUNDICE 27
454 JOINT STIFFNESS 27
455 MELANOCYTIC NAEVUS 27
456 NAIL DISORDER 27
457 NERVE INJURY 27
458 OBESITY 27
459 PULMONARY MASS 27
460 RESTLESS LEGS SYNDROME 27
461 SENSORY DISTURBANCE 27
462 SKIN PAPILLOMA 27
463 WITHDRAWAL SYNDROME 27
464 ACCIDENTAL OVERDOSE 26
465 AGGRESSION 26
466 DRUG LEVEL INCREASED 26
467 HAEMATOMA 26
468 INJECTION SITE HAEMORRHAGE 26
469 MOOD ALTERED 26
470 PLASMA CELL MYELOMA 26
471 PRESYNCOPE 26
472 PRODUCT PRESCRIBING ISSUE 26
473 ROSACEA 26
474 ROTATOR CUFF SYNDROME 26
475 TARDIVE DYSKINESIA 26
476 TASTE DISORDER 26
477 THROAT TIGHTNESS 26
478 AGEUSIA 25
479 BLOOD PRESSURE ABNORMAL 25
480 BONE LOSS 25
481 COLITIS 25
482 EYE DISCHARGE 25
483 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25
484 HEPATIC FUNCTION ABNORMAL 25
485 HEPATIC STEATOSIS 25
486 HIP FRACTURE 25
487 NEPHROPATHY 25
488 PULMONARY OEDEMA 25
489 PUSTULE 25
490 RENAL CYST 25
491 SKIN SWELLING 25
492 TRICHORRHEXIS 25
493 UPPER-AIRWAY COUGH SYNDROME 25
494 ARTERIOSCLEROSIS 24
495 CANDIDA INFECTION 24
496 CLOSTRIDIUM DIFFICILE INFECTION 24
497 DRUG DEPENDENCE 24
498 DYSSTASIA 24
499 EYE INFECTION 24
500 GALLBLADDER DISORDER 24
501 HALLUCINATION, VISUAL 24
502 HYPERKERATOSIS 24
503 ILL-DEFINED DISORDER 24
504 JOINT INJURY 24
505 PRODUCT PHYSICAL ISSUE 24
506 PROSTATE CANCER METASTATIC 24
507 RECTAL HAEMORRHAGE 24
508 RESPIRATORY DISTRESS 24
509 RETCHING 24
510 RHINITIS ALLERGIC 24
511 ROAD TRAFFIC ACCIDENT 24
512 SKIN WEEPING 24
513 SNEEZING 24
514 TINEA PEDIS 24
515 ACUTE RESPIRATORY FAILURE 23
516 AFFECTIVE DISORDER 23
517 ATELECTASIS 23
518 BENIGN PROSTATIC HYPERPLASIA 23
519 CYST 23
520 DECREASED ACTIVITY 23
521 DELIRIUM 23
522 DEMENTIA 23
523 DISABILITY 23
524 EATING DISORDER 23
525 FOLLICULITIS 23
526 HEART RATE IRREGULAR 23
527 LIBIDO DECREASED 23
528 METABOLIC ACIDOSIS 23
529 MULTIPLE ALLERGIES 23
530 PULMONARY FIBROSIS 23
531 SCIATICA 23
532 SUICIDE ATTEMPT 23
533 SWELLING OF EYELID 23
534 TOOTH ABSCESS 23
535 ABNORMAL DREAMS 22
536 APPLICATION SITE IRRITATION 22
537 CARDIAC MURMUR 22
538 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 22
539 DISEASE RECURRENCE 22
540 EXPIRED PRODUCT ADMINISTERED 22
541 FAECES DISCOLOURED 22
542 MITRAL VALVE INCOMPETENCE 22
543 MUCOSAL INFLAMMATION 22
544 MULTIPLE SCLEROSIS 22
545 PNEUMOTHORAX 22
546 PRODUCT LABEL ISSUE 22
547 PRODUCT SUBSTITUTION ISSUE 22
548 PROTEINURIA 22
549 PULMONARY HYPERTENSION 22
550 QUALITY OF LIFE DECREASED 22
551 SINUS CONGESTION 22
552 SKIN MASS 22
553 ANGINA PECTORIS 21
554 APHASIA 21
555 BLOOD PRESSURE FLUCTUATION 21
556 C-REACTIVE PROTEIN INCREASED 21
557 FEEDING DISORDER 21
558 GLYCOSYLATED HAEMOGLOBIN INCREASED 21
559 GOUT 21
560 INFUSION SITE PAIN 21
561 MUSCLE TWITCHING 21
562 NERVOUS SYSTEM DISORDER 21
563 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21
564 RESPIRATORY DISORDER 21
565 SLUGGISHNESS 21
566 XEROSIS 21
567 ACUTE RESPIRATORY DISTRESS SYNDROME 20
568 CHEST X-RAY ABNORMAL 20
569 CHOLESTASIS 20
570 COLITIS ULCERATIVE 20
571 DEVICE MALFUNCTION 20
572 FULL BLOOD COUNT DECREASED 20
573 FURUNCLE 20
574 GASTRIC DISORDER 20
575 GASTROENTERITIS 20
576 HERPES VIRUS INFECTION 20
577 HYPOAESTHESIA ORAL 20
578 INCREASED TENDENCY TO BRUISE 20
579 MICTURITION URGENCY 20
580 NIGHTMARE 20
581 PALLOR 20
582 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20
583 PHARYNGITIS 20
584 PRODUCT USE COMPLAINT 20
585 RASH GENERALISED 20
586 SECRETION DISCHARGE 20
587 ABSCESS 19
588 AORTIC ARTERIOSCLEROSIS 19
589 ARTERIOSCLEROSIS CORONARY ARTERY 19
590 BACK DISORDER 19
591 BRADYKINESIA 19
592 CARDIOMEGALY 19
593 COAGULOPATHY 19
594 DELUSION 19
595 DERMATITIS ALLERGIC 19
596 FREQUENT BOWEL MOVEMENTS 19
597 GASTROENTERITIS VIRAL 19
598 HOSPICE CARE 19
599 IMPETIGO 19
600 INSURANCE ISSUE 19
601 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 19
602 LEG AMPUTATION 19
603 LIGAMENT SPRAIN 19
604 LIVER INJURY 19
605 NEUTROPENIC SEPSIS 19
606 PARANOIA 19
607 PATHOGEN RESISTANCE 19
608 PHARYNGEAL OEDEMA 19
609 PIGMENTATION DISORDER 19
610 PRODUCT PHYSICAL CONSISTENCY ISSUE 19
611 PRODUCT STORAGE ERROR 19
612 PSEUDOMONAS INFECTION 19
613 SPINAL OPERATION 19
614 TRICUSPID VALVE INCOMPETENCE 19
615 VAGINAL HAEMORRHAGE 19
616 ARTHROPOD BITE 18
617 BIPOLAR DISORDER 18
618 BLOOD CREATINE PHOSPHOKINASE INCREASED 18
619 BLOOD PRESSURE SYSTOLIC INCREASED 18
620 BREAST CANCER 18
621 CARDIOMYOPATHY 18
622 CARPAL TUNNEL SYNDROME 18
623 CONTRAINDICATION TO MEDICAL TREATMENT 18
624 COORDINATION ABNORMAL 18
625 COVID-19 PNEUMONIA 18
626 CUSHING^S SYNDROME 18
627 DYSTONIA 18
628 EXOSTOSIS 18
629 GASTRIC ULCER 18
630 GINGIVITIS 18
631 GYNAECOMASTIA 18
632 HYPERCHOLESTEROLAEMIA 18
633 INFUSION SITE ERYTHEMA 18
634 LUNG NEOPLASM MALIGNANT 18
635 MIDDLE INSOMNIA 18
636 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18
637 MUSCLE TIGHTNESS 18
638 NEOPLASM 18
639 NEUROTOXICITY 18
640 PERIORBITAL SWELLING 18
641 PETECHIAE 18
642 PNEUMOCYSTIS JIROVECII PNEUMONIA 18
643 RASH MACULO-PAPULAR 18
644 RENAL FAILURE CHRONIC 18
645 SINUS BRADYCARDIA 18
646 SKIN CANCER 18
647 SUPRAVENTRICULAR TACHYCARDIA 18
648 THYROID DISORDER 18
649 TOXIC EPIDERMAL NECROLYSIS 18
650 VENTRICULAR EXTRASYSTOLES 18
651 ABORTION SPONTANEOUS 17
652 BLOOD TESTOSTERONE DECREASED 17
653 BLOOD UREA INCREASED 17
654 BURSITIS 17
655 EJECTION FRACTION DECREASED 17
656 EXTRA DOSE ADMINISTERED 17
657 FEAR 17
658 HEAD DISCOMFORT 17
659 HIATUS HERNIA 17
660 HYPERTRIGLYCERIDAEMIA 17
661 IMPAIRED QUALITY OF LIFE 17
662 INJECTION SITE MASS 17
663 INJECTION SITE URTICARIA 17
664 KIDNEY INFECTION 17
665 LEUKOCYTOSIS 17
666 LUNG INFILTRATION 17
667 MASS 17
668 MULTIPLE FRACTURES 17
669 ONYCHOMYCOSIS 17
670 ORAL CANDIDIASIS 17
671 POST PROCEDURAL COMPLICATION 17
672 PRODUCT ADMINISTRATION ERROR 17
673 PSYCHOTIC DISORDER 17
674 SCOLIOSIS 17
675 SEBORRHOEA 17
676 SENSITIVE SKIN 17
677 SKIN REACTION 17
678 THROMBOPHLEBITIS SUPERFICIAL 17
679 TOOTH FRACTURE 17
680 VENTRICULAR TACHYCARDIA 17
681 VERTIGO POSITIONAL 17
682 VITREOUS FLOATERS 17
683 ANGER 16
684 BLOOD GLUCOSE ABNORMAL 16
685 BLOOD IMMUNOGLOBULIN E INCREASED 16
686 BLOOD URINE PRESENT 16
687 BODY HEIGHT DECREASED 16
688 BONE LESION 16
689 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 16
690 CONCUSSION 16
691 DIABETIC NEUROPATHY 16
692 DIALYSIS 16
693 EMOTIONAL DISORDER 16
694 EMPHYSEMA 16
695 FOOD ALLERGY 16
696 HAIR GROWTH ABNORMAL 16
697 HALLUCINATION, AUDITORY 16
698 HEPATIC CYTOLYSIS 16
699 HYDRONEPHROSIS 16
700 INJECTION SITE DISCOLOURATION 16
701 INJECTION SITE RASH 16
702 JAW DISORDER 16
703 KNEE ARTHROPLASTY 16
704 LOWER RESPIRATORY TRACT INFECTION 16
705 MALIGNANT MELANOMA 16
706 MIXED LIVER INJURY 16
707 MULTIPLE INJURIES 16
708 NEOPLASM PROGRESSION 16
709 NO THERAPEUTIC RESPONSE 16
710 OBSESSIVE-COMPULSIVE DISORDER 16
711 OESOPHAGITIS 16
712 ONYCHOCLASIS 16
713 ORAL DISORDER 16
714 OTITIS MEDIA 16
715 OTITIS MEDIA ACUTE 16
716 PLATELET COUNT INCREASED 16
717 PRESCRIBED UNDERDOSE 16
718 PRODUCT PRESCRIBING ERROR 16
719 SKIN ABRASION 16
720 SMALL INTESTINAL OBSTRUCTION 16
721 SPINAL FRACTURE 16
722 THINKING ABNORMAL 16
723 VASCULITIS 16
724 ACTIVITIES OF DAILY LIVING IMPAIRED 15
725 AGRANULOCYTOSIS 15
726 ASPERGILLUS TEST POSITIVE 15
727 BLOOD CHLORIDE DECREASED 15
728 BODY TEMPERATURE INCREASED 15
729 BRONCHOSPASM 15
730 COLD SWEAT 15
731 CRYING 15
732 DECUBITUS ULCER 15
733 DERMATITIS ACNEIFORM 15
734 DRUG EFFECT INCOMPLETE 15
735 DRUG WITHDRAWAL SYNDROME 15
736 ENCEPHALOPATHY 15
737 FAILURE TO THRIVE 15
738 FEELING JITTERY 15
739 FRACTURE 15
740 GENERALISED OEDEMA 15
741 GENERALISED TONIC-CLONIC SEIZURE 15
742 GINGIVAL PAIN 15
743 HAIR DISORDER 15
744 HAND FRACTURE 15
745 HEPATOCELLULAR INJURY 15
746 ILEUS 15
747 IMMUNE SYSTEM DISORDER 15
748 INCORRECT PRODUCT ADMINISTRATION DURATION 15
749 INITIAL INSOMNIA 15
750 INJECTION SITE WARMTH 15
751 JOINT EFFUSION 15
752 LABORATORY TEST ABNORMAL 15
753 LOOSE TOOTH 15
754 LYMPHOCYTE COUNT DECREASED 15
755 LYMPHOMA 15
756 PERICARDIAL EFFUSION 15
757 PHARYNGEAL SWELLING 15
758 PNEUMONITIS 15
759 SUBCUTANEOUS ABSCESS 15
760 THERAPEUTIC PRODUCT INEFFECTIVE 15
761 THIRST 15
762 ULCER 15
763 ABDOMINAL PAIN LOWER 14
764 APPLICATION SITE RASH 14
765 ASCITES 14
766 ATRIAL FLUTTER 14
767 AUTOIMMUNE DISORDER 14
768 BEDRIDDEN 14
769 BLOOD IRON DECREASED 14
770 BREAST MASS 14
771 CEREBRAL HAEMORRHAGE 14
772 CHRONIC SINUSITIS 14
773 DEPRESSED LEVEL OF CONSCIOUSNESS 14
774 DIABETIC KETOACIDOSIS 14
775 DRUG ERUPTION 14
776 EPILEPSY 14
777 FISTULA 14
778 FOOT DEFORMITY 14
779 HICCUPS 14
780 HUNGER 14
781 HYPOCALCAEMIA 14
782 HYPOPHOSPHATAEMIA 14
783 IMMUNODEFICIENCY 14
784 IMPAIRED WORK ABILITY 14
785 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14
786 INFUSION SITE EXTRAVASATION 14
787 INJECTION SITE DISCOMFORT 14
788 INTERSTITIAL LUNG DISEASE 14
789 JOINT DISLOCATION 14
790 LENTIGO 14
791 LIP PAIN 14
792 LUMBAR SPINAL STENOSIS 14
793 LYMPHOEDEMA 14
794 MACULE 14
795 MAJOR DEPRESSION 14
796 MANIA 14
797 MENTAL IMPAIRMENT 14
798 METASTASES TO LUNG 14
799 MUSCLE SPASTICITY 14
800 MUSCULOSKELETAL CHEST PAIN 14
801 OCULAR DISCOMFORT 14
802 ORAL DISCOMFORT 14
803 PELVIC PAIN 14
804 PNEUMONIA BACTERIAL 14
805 PRODUCT DISTRIBUTION ISSUE 14
806 PRODUCT PACKAGING ISSUE 14
807 PURULENT DISCHARGE 14
808 REBOUND EFFECT 14
809 SKIN HYPERTROPHY 14
810 SPINAL PAIN 14
811 SQUAMOUS CELL CARCINOMA 14
812 STEVENS-JOHNSON SYNDROME 14
813 TEMPERATURE INTOLERANCE 14
814 UPPER LIMB FRACTURE 14
815 VESTIBULAR DISORDER 14
816 VITAMIN D DECREASED 14
817 WRIST FRACTURE 14
818 ABASIA 13
819 ABSCESS LIMB 13
820 APPLICATION SITE SWELLING 13
821 BLOOD CREATININE DECREASED 13
822 BODY TINEA 13
823 CHOLECYSTECTOMY 13
824 CLOSTRIDIUM DIFFICILE COLITIS 13
825 COMPLICATION ASSOCIATED WITH DEVICE 13
826 COMPRESSION FRACTURE 13
827 DEAFNESS BILATERAL 13
828 DERMATITIS PSORIASIFORM 13
829 DEVICE RELATED INFECTION 13
830 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13
831 DRUG PRESCRIBING ERROR 13
832 EAR DISCOMFORT 13
833 ECCHYMOSIS 13
834 EXTRAPYRAMIDAL DISORDER 13
835 FEMUR FRACTURE 13
836 HAEMATEMESIS 13
837 HEPATITIS FULMINANT 13
838 HERNIA 13
839 INFUSION SITE SWELLING 13
840 IRON DEFICIENCY ANAEMIA 13
841 LARYNGITIS 13
842 LOW DENSITY LIPOPROTEIN INCREASED 13
843 LUNG CONSOLIDATION 13
844 LYMPHOPENIA 13
845 MEDICATION ERROR 13
846 METASTASES TO LIVER 13
847 MYOSITIS 13
848 NERVE COMPRESSION 13
849 PERFORMANCE STATUS DECREASED 13
850 PNEUMONIA MYCOPLASMAL 13
851 POST-TRAUMATIC STRESS DISORDER 13
852 PRODUCT PREPARATION ERROR 13
853 PRURITUS GENERALISED 13
854 PSYCHOMOTOR HYPERACTIVITY 13
855 RASH PUSTULAR 13
856 RESPIRATORY TRACT CONGESTION 13
857 SEDATION 13
858 SPINAL DISORDER 13
859 SPINAL FUSION SURGERY 13
860 SPLENOMEGALY 13
861 THERMAL BURN 13
862 TOOTH EXTRACTION 13
863 UPPER GASTROINTESTINAL HAEMORRHAGE 13
864 ADRENOCORTICAL INSUFFICIENCY ACUTE 12
865 ANAL INCONTINENCE 12
866 AORTIC ANEURYSM 12
867 APHONIA 12
868 BACTERIAL TEST POSITIVE 12
869 BLINDNESS 12
870 BLOOD MAGNESIUM DECREASED 12
871 BONE DEMINERALISATION 12
872 BOWEL MOVEMENT IRREGULARITY 12
873 BREAST PAIN 12
874 CENTRAL NERVOUS SYSTEM LESION 12
875 CRYPTOCOCCOSIS 12
876 DIABETES MELLITUS INADEQUATE CONTROL 12
877 DIZZINESS POSTURAL 12
878 DRUG EXPOSURE DURING PREGNANCY 12
879 ESSENTIAL HYPERTENSION 12
880 FEELING DRUNK 12
881 FOOD POISONING 12
882 FORMICATION 12
883 GLOSSODYNIA 12
884 HYPERCALCAEMIA 12
885 HYPOALBUMINAEMIA 12
886 HYPOMAGNESAEMIA 12
887 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 12
888 INTENTIONAL OVERDOSE 12
889 LIP DRY 12
890 LOWER LIMB FRACTURE 12
891 MENISCUS INJURY 12
892 METASTASES TO SPINE 12
893 MUSCULOSKELETAL DISORDER 12
894 MYCOBACTERIUM AVIUM COMPLEX INFECTION 12
895 MYDRIASIS 12
896 NOSOCOMIAL INFECTION 12
897 OBSTRUCTIVE SLEEP APNOEA SYNDROME 12
898 OSTEITIS 12
899 OVARIAN CYST 12
900 PANCREATITIS ACUTE 12
901 PARAESTHESIA ORAL 12
902 PERIPHERAL VASCULAR DISORDER 12
903 PERITONITIS 12
904 PITUITARY-DEPENDENT CUSHING^S SYNDROME 12
905 POSTOPERATIVE WOUND INFECTION 12
906 PRODUCT AVAILABILITY ISSUE 12
907 PRODUCT RESIDUE PRESENT 12
908 PSYCHOLOGICAL TRAUMA 12
909 PULMONARY CONGESTION 12
910 PULMONARY GRANULOMA 12
911 PULMONARY HAEMORRHAGE 12
912 PURPURA SENILE 12
913 SINUS TACHYCARDIA 12
914 TARSAL TUNNEL SYNDROME 12
915 TENDONITIS 12
916 TINEA CRURIS 12
917 TINEA VERSICOLOUR 12
918 VISUAL ACUITY REDUCED 12
919 ABNORMAL FAECES 11
920 ADRENAL SUPPRESSION 11
921 ATRIOVENTRICULAR BLOCK COMPLETE 11
922 BACK INJURY 11
923 BLINDNESS UNILATERAL 11
924 BODY TEMPERATURE DECREASED 11
925 CHEMICAL BURN 11
926 CHOKING 11
927 CHOLECYSTITIS 11
928 CLOSTRIDIUM TEST POSITIVE 11
929 CORONARY ARTERY OCCLUSION 11
930 CYSTITIS HAEMORRHAGIC 11
931 DERMAL CYST 11
932 DEVICE LEAKAGE 11
933 DIVERTICULUM INTESTINAL 11
934 DROOLING 11
935 ERUCTATION 11
936 FACIAL PAIN 11
937 FLANK PAIN 11
938 FOETAL EXPOSURE DURING PREGNANCY 11
939 GASTROINTESTINAL INFECTION 11
940 GUTTATE PSORIASIS 11
941 IMPAIRED DRIVING ABILITY 11
942 INCONTINENCE 11
943 INCORRECT DRUG ADMINISTRATION DURATION 11
944 INFUSION SITE HAEMORRHAGE 11
945 INJECTION SITE VESICLES 11
946 INTENTIONAL SELF-INJURY 11
947 LOCAL SWELLING 11
948 MOOD SWINGS 11
949 MOUTH SWELLING 11
950 NEEDLE ISSUE 11
951 NEURODERMATITIS 11
952 NORMOCHROMIC NORMOCYTIC ANAEMIA 11
953 OROPHARYNGEAL DISCOMFORT 11
954 PHOTOPSIA 11
955 PRODUCT COLOUR ISSUE 11
956 PRODUCT DISPENSING ERROR 11
957 PRODUCT ODOUR ABNORMAL 11
958 PROSTATOMEGALY 11
959 PRURITUS GENITAL 11
960 RAYNAUD^S PHENOMENON 11
961 RESORPTION BONE INCREASED 11
962 SALIVARY HYPERSECRETION 11
963 SENSORY LOSS 11
964 SUNBURN 11
965 UROSEPSIS 11
966 ABNORMAL LOSS OF WEIGHT 10
967 ANAPHYLACTIC SHOCK 10
968 ANEURYSM 10
969 ANOREXIA 10
970 APHTHOUS ULCER 10
971 APPLICATION SITE DRYNESS 10
972 APPLICATION SITE EXFOLIATION 10
973 APPLICATION SITE VESICLES 10
974 BLINDNESS TRANSIENT 10
975 BRAIN INJURY 10
976 CARDIOVASCULAR DISORDER 10
977 COLON CANCER 10
978 DEFORMITY 10
979 DIASTOLIC DYSFUNCTION 10
980 DRUG ADMINISTERED AT INAPPROPRIATE SITE 10
981 DRUG DOSE OMISSION BY DEVICE 10
982 ELECTROCARDIOGRAM ABNORMAL 10
983 ERYTHEMA MULTIFORME 10
984 ERYTHEMA OF EYELID 10
985 GINGIVAL BLEEDING 10
986 GLUCOSE TOLERANCE IMPAIRED 10
987 HEPATITIS CHOLESTATIC 10
988 HEPATOMEGALY 10
989 HEPATOSPLENOMEGALY 10
990 HYPERTRANSAMINASAEMIA 10
991 HYPOGONADISM 10
992 IDIOPATHIC INTRACRANIAL HYPERTENSION 10
993 INCOHERENT 10
994 INTRAOCULAR PRESSURE INCREASED 10
995 LEFT VENTRICULAR HYPERTROPHY 10
996 MACULAR DEGENERATION 10
997 MENINGITIS ASEPTIC 10
998 MUSCLE ATROPHY 10
999 MUSCLE FATIGUE 10